tiprankstipranks
Pliant Therapeutics (PLRX)
NASDAQ:PLRX
US Market

Pliant Therapeutics (PLRX) Income Statement

Compare
498 Followers

Pliant Therapeutics Income Statement

Last quarter (Q3 2024), Pliant Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Pliant Therapeutics's net income was $-57.76M. See Pliant Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.58M$ 9.69M$ 7.57M$ 41.82M$ 57.05M
Gross Profit
$ 1.58M$ 6.00M$ 4.37M$ 41.82M$ 57.05M
Operating Expenses
$ 185.72M$ 136.88M$ 27.56M$ 83.46M$ 58.28M
Depreciation and Amortization
$ 1.84M$ 3.68M$ 3.20M$ 1.31M$ 1.11M
EBITDA
$ -158.23M$ -118.85M$ -95.73M$ -40.34M$ -118.00K
Operating Income
$ -184.15M$ -127.20M$ -19.99M$ -41.65M$ -1.23M
Other Income/Expenses
$ 22.81M$ 3.88M$ 272.00K$ 112.00K$ 600.00K
Pretax Income
$ -161.34M$ -123.32M$ -19.71M$ -41.53M$ -631.00K
Net Income
$ -161.34M$ -121.50M$ -17.91M$ -39.74M$ 185.00K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.75$ -2.89$ -0.50$ -1.12$ 0.01
Diluted EPS
$ -2.75$ -2.89$ -0.50$ -1.12$ 0.01
Weighted Average Shares Outstanding
58.72M 42.02M 35.85M 35.55M 35.55M
Weighted Average Shares Outstanding (Diluted)
58.72M 42.02M 35.85M 35.55M 35.55M
Currency in USD

Pliant Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis